Fortune 500 Europe

Page 13 of 23

Novo Nordisk President and CEO Lars Fruergaard Jorgensen testifies before the Senate Health, Education, Labor, and Pensions Committee in the Dirksen Senate Office Building on Capitol Hill on September 24, 2024 in Washington, DC. The committee heard testimony from Jorgensen about the price of popular pharmaceuticals made by Novo Nordisk that help treat diabetes and obesity, including Wegovy and Ozempic.
Leadership

As U.S. firms scrap diversity targets, the CEO behind Ozempic and Wegovy took a pay cut for missing them

By
February 5, 2025
Karsten Munk Knudsen, chief financial officer of Novo Nordisk A/S, at the company's headquarters in Bagsvaerd, Denmark, on Tuesday, Nov. 26, 2024.
Health

As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs

By
February 5, 2025
Santander profits rise for third straight year, chair Ana Botin says ‘in a challenging market we outperform peers’
Finance

Santander profits rise for third straight year, chair Ana Botin says ‘in a challenging market we outperform peers’

By
February 5, 2025
GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales
Finance

GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales

By
February 5, 2025
Christian Luiga, chief financial officer of TeliaSonera AB, speaks during a news conference to announce earnings at the company's headquarters in Stockholm, Sweden, on Thursday, Jan. 29, 2015.
Tech

Daniel Ek says Spotify’s new CFO, a former defense exec, is ditching his suits for t-shirts as streaming giant breaks fresh records

By
February 5, 2025
Spotify shares surge on subscriber gains, first annual profit
Finance

Spotify shares surge on subscriber gains, first annual profit

By Ashley Carman and Bloomberg
February 4, 2025
Novo Nordisk advertising logo on facade building, Danish pharmaceutical healthcare giant Novo Nordisk AS, production innovative drugs, obesity treatment Ozempic, Mainz, Germany June 15, 2024
Health

Investors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results

By
February 4, 2025
bottles lined up on a table
Retail

Tariffs add a new twist as Don Julio tequila and Guinness maker Diageo faces a rocky 2025

By
February 4, 2025
UBS profit beats forecast as Swiss banking giant eyes full Credit Suisse merger
Finance

UBS profit beats forecast as Swiss banking giant eyes full Credit Suisse merger

By Nathalie Olof-Ors, Robin Millard and AFP
February 4, 2025
A person stands on a scale.
Health

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

By
February 3, 2025
L’Oreal sells €3 billion of Sanofi stock back to drugmaker
Finance

L’Oreal sells €3 billion of Sanofi stock back to drugmaker

By Phil Serafino, Angelina Rascouet and Bloomberg
February 3, 2025
Julius Baer announces 400 job cuts, executive board revamp
Finance

Julius Baer announces 400 job cuts, executive board revamp

By Noele Illien and Bloomberg
February 3, 2025
Mads Nipper
Environment

Danish wind giant Orsted replaces its CEO with shares down 83% and Trump pressures looming

By
January 31, 2025
Sweden’s Electrolux reports strong financial turnaround—but remains cautious of Trump’s trade policies that could hit demand
Finance

Sweden’s Electrolux reports strong financial turnaround—but remains cautious of Trump’s trade policies that could hit demand

By
January 31, 2025
Europe’s banks kick off sweeping job cuts in ‘Year of Reckoning’
Finance

Europe’s banks kick off sweeping job cuts in ‘Year of Reckoning’

By Harry Wilson and Bloomberg
January 31, 2025

Most Popular